Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global High Throughput Process Development Market to Grow at a CAGR of 15% by 2023: Key Players are Danaher Corporation, GE Healthcare, Thermo Fisher Scientific, Merck Millipore & Agilent Technologies - Research and Markets

Research and Markets
Posted on: 02 Aug 17

The "Global High Throughput Process Development Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023" report has been added to Research and Markets' offering.

The global high throughput process development market is expected to grow at a CAGR of 15% during the forecast period.

The key factor driving the segment growth is the increased adoption of targeted immunotherapy and the increasing number of therapeutic monoclonal antibodies approved by U.S. FDA . Report further covers segments of process type; the market is segmented into upstream processing and downstream processing. The downstream processing is the leading segment and had accounted for largest market revenue share in 2016 due to the increasing demand of purified biosimilars, whereas the end user includes contract manufacturing organizations and biopharmaceutical manufacturers.

North America is the leading market region for high throughput process development market and had accounted for the largest market revenue share in 2016. The key factors boosting the growth of global high throughput process development market in North America region is the rising expenditure on R&D infrastructure by the pharmaceutical and biopharmaceutical industries. Moreover, there is increasing demand for technologically advanced tools to enhance the production quality of biological materials in North America.

Companies Mentioned

  • Agilent Technologies, Inc. (U.S.)
  • Amgen Inc. (U.S.)
  • Biogen Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Celgene Corporation (U.S.)
  • Danaher Corporation (U.S.)
  • Eppendorf Ag (Germany)
  • Ge Healthcare (UK)
  • Illumina Inc. (U.S.)
  • Merck Millipore (U.S.)
  • Perkinelmer, Inc. (U.S.)
  • Sartorius Stedim Biotech (France)
  • Sun Pharma (India)
  • Tecan Group Ltd. (Switzerland)
  • Thermo Fisher Scientific Inc. (U.S.)

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Geographical Analysis

7. Company Profiles

For more information about this report visit

View source version on

Business Wire

Last updated on: 02/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.